Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: Ly3502970 hemicalcium, Ly-3502970 hemicalcium, Vi5m9ozv2x, 2415797-61-2, Refchem:1093902, Orforglipron hemicalcium
Molecular Formula
C96H94CaF4N20O10
Molecular Weight
1804.0  g/mol
InChI Key
QBDWQKSMTIYJPN-IDSDWNPTSA-L
FDA UNII
VI5M9OZV2X

ORFORGLIPRON CALCIUM is a small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
calcium bis(3-[(1S,2S)-1-[5-[(4S)-2,2-dimethyloxan-4-yl]-2-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carbonyl]indol-1-yl]-2-methylcyclopropyl]-1,2,4-oxadiazol-5-olate)
2.1.2 InChI
InChI=1S/2C48H48F2N10O5.Ca/c2*1-25-18-32(19-26(2)40(25)49)60-42(58-16-15-57(46(58)63)37-11-10-36-33(41(37)50)24-51-55(36)7)39-28(4)56(14-12-34(39)53-60)43(61)38-21-31-20-29(30-13-17-64-47(5,6)23-30)8-9-35(31)59(38)48(22-27(48)3)44-52-45(62)65-54-44;/h2*8-11,15-16,18-21,24,27-28,30H,12-14,17,22-23H2,1-7H3,(H,52,54,62);/q;;+2/p-2/t2*27-,28-,30-,48-;/m00./s1
2.1.3 InChI Key
QBDWQKSMTIYJPN-IDSDWNPTSA-L
2.2 Other Identifiers
2.2.1 UNII
VI5M9OZV2X
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Ly3502970 Hemicalcium

2. Ly-3502970 Hemicalcium

3. Vi5m9ozv2x

4. 2415797-61-2

5. Refchem:1093902

6. Orforglipron Hemicalcium

7. Chembl5314577

8. Orforglipron Calcium (jan/usan)

9. Orforglipron Calcium [usan]

10. D12529

11. 1,2,4-oxadiazol-5(2h)-one, 3-[(1s,2s)-1-[2-[[(4s)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methyl-1h-indazol-5-yl)-2,3-dihydro-2-oxo-1h-imidazol-1-yl]-2,4,6,7-tetrahydro-4-methyl-5h-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(4s)-tetrahydro-2,2-dimethyl-2h-pyran-4-yl]-1h-indol-1-yl]-2-methylcyclopropyl]-, Calcium Salt (2:1)

12. Calcium Bis{3-[(1s,2s)-1-({2-(4-fluoro-3,5-dimethylphenyl)-3-({3-[3-(4-fluoro-1-methyl-1h-indazol-5-yl)-2-oxo-2,3-dihydro-1h-imidazol-1-yl]-4-methyl-2,4,6,7-tetrahydro-5h-pyrazolo[4,3-c]pyridin-5-yl}carbonyl)-5-[(4s)-2,2-dimethyloxan-4-yl]-1h-indol-1-yl}-2-methylcyclopropyl]-5-oxo-1,2,4-oxadiazol-4(5h)-ide}

2.4 Create Date
2023-04-17
3 Chemical and Physical Properties
Molecular Weight 1804.0 g/mol
Molecular Formula C96H94CaF4N20O10
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count22
Rotatable Bond Count14
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area311
Heavy Atom Count131
Formal Charge0
Complexity1840
Isotope Atom Count0
Defined Atom Stereocenter Count8
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3